Bobby Gaspar - Mar 1, 2023 Form 4 Insider Report for Orchard Therapeutics plc (ORTX)

Role
Chief Executive Officer, Director
Signature
/s/ Frank E. Thomas, as Attorney-in-Fact
Stock symbol
ORTX
Transactions as of
Mar 1, 2023
Transactions value $
$0
Form type
4
Date filed
3/3/2023, 05:00 PM
Previous filing
Oct 6, 2022
Next filing
Jan 24, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ORTX Stock Option (Right to Buy) Award $0 +563K $0.00 563K Mar 1, 2023 Ordinary Shares 563K $0.46 Direct F1, F2
transaction ORTX Stock Option (Right to Buy) Award $0 +582K $0.00 582K Mar 1, 2023 Ordinary Shares 582K $0.58 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares subject to this option shall vest and become exercisable in forty-eight (48) equal monthly installments, with the first installment vesting on April 1, 2023.
F2 The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.